GLP-3RT Research Summary: What Lilly’s Published Trials Reported
What Eli Lilly's published phase 1, 2 and 3 studies of GLP-3RT (LY3437943) reported, credited to Lilly and the journals, plus its drug-or-biologic classification, regulatory status and storage. Research use only.
Read more →
